From the Service de Pharmacologie, Faculté de Médecine, Monastir, Tunisia.
World Allergy Organ J. 2010 Jul;3(7):220-2. doi: 10.1097/WOX.0b013e3181eab930.
The anticonvulsant hypersensitivity syndrome, also known as drug rash eosinophilia and systemic symptoms (DRESS), is a rare but severe form of adverse cutaneous reaction. Several aromatic anticonvulsant drugs, such as carbamazepine (CBZ), phenytoin, or phenobarbital have been frequently associated with the onset of DRESS. Cross-reactivity among the aromatic anticonvulsants frequently occurs (40 to 80% of patients). However, cross reactivity with other drugs such as betalactams have exceptionally been reported. We report a clinical observation describing a DRESS associated with CBZ with a subsequent hypersensitivity to amoxicillin (AMX). A 34-year-old male with a 20-year history of epilepsy was treated with valproic acid and phenobarbital. As he had frequent convulsive fits, CBZ was added. Thirty-four days later, the patient developed hyperthermia (39.5°C), cervical lymphadenopathy, and generalized cutaneous exfoliated maculae and papulae. Biochemical investigation was characterized by a white cell count of (16.1 × 103/μL, 17% eosinophils) and increased levels of aspartate aminotransferase and alanine aminotransferase (50 and 116 IU/L, respectively). CBZ was discontinued. One month later, all the symptoms were progressively relieved. Six weeks after complete recovery, prick and patch skin tests were performed. They were strongly positive at 48-hour reading. About 2 years later, the patient exhibited an extensive pruritic skin rash, 2 days after AMX intake. Laboratory exams showed eosinophilia (7%) but neither elevated liver enzymes nor renal dysfunction. All these symptoms have disappeared 5 days after AMX withdrawal. Intradermal test to AMX was positive but not to other betalactams. Throughout this clinical observation, we report a CBZ-induced DRESS and describe the possibility of cross reactivity between CBZ and AMX. This cross reactivity was observed despite the lack of chemical similarity between both drugs.
抗惊厥过敏综合征,又称药物疹伴嗜酸性粒细胞增多和全身症状(DRESS),是一种罕见但严重的不良皮肤反应。几种芳香族抗惊厥药物,如卡马西平(CBZ)、苯妥英或苯巴比妥,常与 DRESS 的发病有关。芳香族抗惊厥药物之间经常发生交叉反应(40%至 80%的患者)。然而,与其他药物如β内酰胺类药物的交叉反应也有例外报道。我们报告了一个临床观察,描述了与 CBZ 相关的 DRESS,随后对阿莫西林(AMX)过敏。一名 34 岁男性患有 20 年癫痫病史,曾接受丙戊酸和苯巴比妥治疗。由于他经常发作癫痫,因此添加了 CBZ。34 天后,患者出现高热(39.5°C)、颈淋巴结肿大以及全身皮肤剥落的红斑和丘疹。生化检查表现为白细胞计数(16.1×103/μL,17%嗜酸性粒细胞)升高和天冬氨酸转氨酶和丙氨酸转氨酶水平升高(分别为 50 和 116 IU/L)。停用 CBZ。一个月后,所有症状逐渐缓解。完全恢复后 6 周进行了皮试和斑贴试验。48 小时读数时呈强阳性。大约 2 年后,患者在服用 AMX 后 2 天出现广泛瘙痒性皮疹。实验室检查显示嗜酸性粒细胞增多(7%),但肝酶和肾功能均未升高。所有这些症状在 AMX 停药 5 天后均消失。AMX 皮内试验阳性,但对其他β内酰胺类药物阴性。在整个临床观察过程中,我们报告了 CBZ 诱导的 DRESS,并描述了 CBZ 和 AMX 之间可能发生交叉反应。尽管两种药物之间没有化学相似性,但仍观察到这种交叉反应。